[Double-blind comparison of a betamethasone dipropionate-iodochloroxyquinoline combination and a flumethasone pivalate-iodochloroxyquinoline combination in the therapy of steroid-sensitive dermatoses with superinfection].
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D001623:Betamethasone / Q000031:analogs & derivatives / Q000627:therapeutic use; D002648:Child; D007464:Clioquinol / Q000627:therapeutic use; D004311:Double-Blind Method; D004338:Drug Combinations; D005260:Female; D005443:Flumethasone / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D012871:Skin Diseases / Q000188:drug therapy*; D012874:Skin Diseases, Infectious / Q000188:drug therapy
D004338:Drug Combinations; C005565:flumethasone pivalate; D007464:Clioquinol; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone; D005443:Flumethasone
Confronto in doppio cieco fra l'associazione betametasone dipropionato-iodoclorossichinolina e l'associazione flumetasone pivalato e iodoclorossichinolina nella terapia delle dermatosi steroidosensibili con superinfezione.